Janssen, Alexander http://orcid.org/0000-0003-0719-0831
Bennis, Frank C.
Cnossen, Marjon H.
Mathôt, Ron A. A.
,
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWA.1160.18.038)
Article History
Received: 17 November 2023
Accepted: 9 February 2024
First Online: 26 March 2024
Declarations
:
: M.H.C.'s institution has received investigator-initiated research and travel grants as well as speaker fees over the years from the Netherlands Organization for Scientific Research (NWO) and Netherlands National research Agenda (NWA), the Netherlands Organization for Health Research and Development (ZonMw), the Dutch Innovatiefonds Zorgverzekeraars, Baxter/Baxalta/Shire/Takeda, Pfizer, Bayer Schering Pharma, CSL Behring, Sobi Biogen, Novo Nordisk, Novartis and Nordic Pharma and for serving as a steering board member for Roche, Bayer and Novartis for which fees go to the Erasmus MC as an institution. R.A.A.M. has received grants from governmental and societal research institutes such as NWO, ZonMW, Dutch Kidney Foundation and Innovation Fund and unrestricted investigator research grants from Baxter/Baxalta/ Shire/Takeda, Bayer, CSL Behring, Sobi and CelltrionHC. He has served as advisor for Bayer, CSL Behring, Merck Sharp & Dohme and Baxter/Baxalta/Shire/Takeda. All grants and fees paid to the institution. A.J., and F.C.B. have no conflicts of interest to declare.